EQUITY RESEARCH MEMO

Gurus

Generated 5/9/2026

Executive Summary

Conviction (model self-assessment)55/100

Gurus, founded in 2019 and based in Yerevan, Armenia, is a specialized biometrics services company serving global CROs, pharmaceutical, and biotechnology companies. The firm offers clinical data management, statistical programming (SAS and R), biostatistics, and CDISC submission support. With a team of 51-200 employees, Gurus differentiates itself through a training academy that develops talent in statistical programming and biostatistics, ensuring a skilled workforce. Operating in the AI/Machine Learning and Drug Delivery categories, the company is well-positioned to capitalize on the growing demand for outsourced clinical data services. Its private status and niche focus provide flexibility and expertise, though it faces competition from larger CROs. The company's location in Armenia offers cost advantages while maintaining high-quality standards.

Upcoming Catalysts (preview)

  • Q2 2026Expansion of client portfolio through strategic partnerships with mid-tier pharma65% success
  • Q3 2026Release of new AI-driven data management tools40% success
  • Q4 2026Achievement of CDISC certification for new therapeutic areas50% success
Locked sections
  • · Pipeline Analysis
  • · Competitive Landscape
  • · Catalyst Calendar (full 12-month)
  • · Bull Case
  • · Bear Case
  • · Counterfactual Scenarios
  • · Valuation Notes
  • · SEC Filing Highlights
  • · Insider Activity
  • · Literature Watch
  • · Patent Landscape
  • · Mechanism Cluster Map
  • · Audio Briefing (5 min)